Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 2/20 | 0.72 |
| ▸ | JUN | P05412 | 1/20 | 0.72 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.64 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.64 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.64 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.64 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.64 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.64 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.64 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.64 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.64 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.64 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.64 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.64 |
| ▸ | TNKS | O95271 | 1/20 | 0.64 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.64 |
| ▸ | CA12 | O43570 | 2/20 | 0.59 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.59 |
| ▸ | CA1 | P00915 | 2/20 | 0.59 |
| ▸ | CA2 | P00918 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL333511 | 1.00 | NFKB1 (0.72) | NFKB1JUNHCAR2HDAC1HDAC6 | |
| SCHEMBL5717836 | 1.00 | NFKB1 (0.72) | NFKB1JUNHCAR2HDAC1HDAC6 | |
| Hydrochloric Acid SCHEMBL7439430 | 0.98 | NFKB1 (0.69) | NFKB1JUNHCAR2HDAC1HDAC6 | |
| Hydrochloric Acid SCHEMBL7439425 | 0.98 | NFKB1 (0.69) | NFKB1JUNHCAR2HDAC1HDAC6 | |
| SCHEMBL7978817 | 0.96 | NFKB1 (0.67) | NFKB1JUNHCAR2HDAC1HDAC6 | |
| SCHEMBL7978810 | 0.96 | NFKB1 (0.67) | NFKB1JUNHCAR2HDAC1HDAC6 | |
| SCHEMBL7978819 | 0.96 | NFKB1 (0.67) | NFKB1JUNHCAR2HDAC1HDAC6 | |
| SCHEMBL7978812 | 0.96 | NFKB1 (0.67) | NFKB1JUNHCAR2HDAC1HDAC6 | |
| SCHEMBL11826842 | 0.88 | HCAR2 (0.57) | NFKB1JUNHCAR2HDAC1HDAC6 | |
| SCHEMBL11826834 | 0.88 | HCAR2 (0.57) | NFKB1JUNHCAR2HDAC1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 508 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220402930-A1 | USE OF NOVEL COMPOUND, FOR PREVENTING, IMPROVING OR TREATING AMYOTROPHIC LATERAL SCLEROSIS | PRG S&TECH INC. (KR) | 2022-12-22 | — | — | US | claimed |
| EP-4056573-A1 | USE OF NOVEL COMPOUND, FOR PREVENTING, IMPROVING OR TREATING AMYOTROPHIC LATERAL SCLEROSIS | PRG S&Tech Inc. (KR) | 2022-09-14 | — | — | EP | claimed |
| CN-114929711-A | Use of novel compounds for preventing, ameliorating or treating amyotrophic lateral sclerosis | PRG科技株式会社 | 2022-08-19 | — | — | CN | claimed |
| US-20220039382-A1 | METHOD AND COMPOUNDS TO INDUCE PLANT TOLERANCE AGAINST ARTHROPOD PESTS | UNIVERSITEIT GENT (BE) | 2022-02-10 | — | — | US | claimed |
| EP-3897147-A1 | METHOD AND COMPOUNDS TO INDUCE PLANT TOLERANCE AGAINST ARTHROPOD PESTS | Universiteit Gent (BE) | 2021-10-27 | — | — | EP | claimed |
| WO-2021086101-A1 | USE OF NOVEL COMPOUND, FOR PREVENTING, IMPROVING OR TREATING AMYOTROPHIC LATERAL SCLEROSIS | (주)피알지에스앤텍 | 2021-05-06 | — | — | WO | claimed |
| CN-111918881-A | Novel photocrosslinkable alginic acid derivative | 持田制药株式会社 | 2020-11-10 | — | — | CN | claimed |
| EP-3726990-A1 | COMPOUNDS FOR CONTROLLING PLANT PATHOGENS | Universiteit Gent (BE) | 2020-10-28 | — | — | EP | claimed |
| US-20200305428-A1 | COMPOUNDS FOR CONTROLLING PLANT PATHOGENS | UNIVERSITEIT GENT (BE) | 2020-10-01 | — | — | US | claimed |
| WO-2020127216-A1 | METHOD AND COMPOUNDS TO INDUCE PLANT TOLERANCE AGAINST ARTHROPOD PESTS | UNIVERSITEIT GENT (BE) | 2020-06-25 | — | — | WO | claimed |
| EP-2969029-A2 | USE OF COSMETICALLY OR DERMATOLOGICALLY SAFE SUBSTITUTED MICHAEL ACCEPTORS FOR THE PREVENTION, REDUCTION OR PROPHYLAXIS OF THE TYROSINASE ACTIVITY OF THE HUMAN SKIN AND/OR THE LIGHTENING OF THE HUMAN SKIN | Beiersdorf AG (DE) | 2016-01-20 | — | — | EP | claimed |
| US-20150320667-A1 | MOLECULARLY IMPRINTED POLYMER FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | L'OREAL (FR) | 2015-11-12 | — | — | US | claimed |
| CN-105050663-A | Use of cosmetically and dermatologically safe substituted michael acceptors to prevent, reduce or prevent human skin tyrosinase activity and/or to lighten skin | BEIERSDORF AG | 2015-11-11 | — | — | CN | claimed |
| EP-2790260-A1 | COMPOSITION FOR GEL POLYMER ELECTROLYTE AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG Chem, Ltd. (KR) | 2014-10-15 | — | — | EP | claimed |
| EP-2782182-A1 | LITHIUM SECONDARY BATTERY | LG Chem, Ltd. (KR) | 2014-09-24 | — | — | EP | claimed |
| WO-2014139756-A2 | USE OF COSMETICALLY OR DERMATOLOGICALLY SAFE SUBSTITUTED MICHAEL ACCEPTORS FOR THE PREVENTION, REDUCTION OR PROPHYLAXIS OF THE TYROSINASE ACTIVITY OF THE HUMAN SKIN AND/OR THE LIGHTENING OF THE HUMAN SKIN | BEIERSDORF AG (DE) | 2014-09-18 | — | — | WO | claimed |
| US-20140220452-A1 | LITHIUM SECONDARY BATTERY | LG CHEM, LTD. (KR) | 2014-08-07 | — | — | US | claimed |
| US-20140220427-A1 | COMPOSITION FOR GEL POLYMER ELECTROLYTE AND LITHIUM SECONDARY BATTERY INCLUDING THE SAME | LG CHEM, LTD. (KR) | 2014-08-07 | — | — | US | claimed |
| US-8608932-B2 | Cyanide-free silver electroplating solutions | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2013-12-17 | — | — | US | claimed |
| US-20120067735-A1 | CYANIDE-FREE SILVER ELECTROPLATING SOLUTIONS | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2012-03-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220039382-A1 | METHOD AND COMPOUNDS TO INDUCE PLANT TOLERANCE AGAINST ARTHROPOD PESTS | BROX, DDT, CAT | NFKB1 3663/4885JUN 2569/4885HCAR2 3116/4885 |
| US-20200305428-A1 | COMPOUNDS FOR CONTROLLING PLANT PATHOGENS | HPD, HAAO, NCEH1 | NFKB1 1769/4885JUN 2672/4885HCAR2 340/4885 |
| US-20220402930-A1 | USE OF NOVEL COMPOUND, FOR PREVENTING, IMPROVING OR TREATING AMYOTROPHIC LATERAL SCLEROSIS | SOD1, SLC75A1, SLC43A1 | NFKB1 2099/4885JUN 3245/4885HCAR2 3874/4885 |
| US-20150320667-A1 | MOLECULARLY IMPRINTED POLYMER FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | OR10J3, OR51E2, MSMO1 | NFKB1 4857/4885JUN 4827/4885HCAR2 2620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.